从交易成本理论视角来看，生物医药孵化器在具有实现创新资源共享、降低市场交易成本等作用的同时，其运营发展过程中也会产生比较高的信息成本、协调成本及监督成本。分入孵、在孵两个阶段，分析提出我国生物医药孵化器运营成本问题的成因主要包括信息共享不足、运行机制不够健全以及监督体系有待完善等方面，结合对美国强生JLabs生物医药孵化器的案例分析，从交易成本视角为降低我国生物医药孵化器运营成本、提高孵化能力，提出加强信息共享建设、制定健全运行机制和构建完善监督体系等具体对策建议。

From the perspective of transaction cost theory, biomedical incubators not only help to achieve innovative resource sharing and reduce market transaction costs, but also produce relatively high information costs, coordination costs and supervision costs in the process of operation and development. Divided into two stages of incubation and in incubation, this paper analyzes and puts forward the causes of the operation cost of biomedical incubators in China, mainly including insufficient information sharing, imperfect operation mechanism and imperfect supervision system. Combined with the case analysis of Johnson & Johnson JLabs biomedical incubator in the United States, this paper aims to reduce the operation cost of biomedical incubators in China from the perspective of transaction cost Improve the incubation ability, and put forward specific countermeasures and suggestions such as strengthening the construction of information sharing, formulating and perfecting the operation mechanism and constructing and perfecting the supervision system.

国家社会科学基金重大项目“我国创新药物政策环境研究”（15ZDB167)；江苏省科技计划政策引导类（软科学研究）项目“产学研深度融合的江苏省生物医药技术创新体系建设研究”（BR2020089）